Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01034761 · ClinicalTrials.gov registry record · NA

Using Clinical Alerts to Decrease Inappropriate Medication Prescribing

A NA study, sponsored by Baystate Medical Center.

Completed
Registry status
NA
Development phase
719
Enrollment target

NCT01034761 is a NA study that has completed, run by Baystate Medical Center. The registered enrollment target is 719 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01034761, a NA study, has completed, sponsored by Baystate Medical Center.

COMPLETED
Registry status
NA
Development phase
719 participants
Enrollment target

Study Summary

Introduction: The Beers list identifies medications that should be avoided in persons 65 years or older because they are ineffective, pose an unnecessarily high risk, or a safer alternative is available. In a recent study, we found a high rate of prescribing of Beers list medications to hospitalized patients. At Baystate, 41% of medical patients received at least one Beers list drug classified as "high severity," meaning it carried a high risk for an adverse drug reaction, while 5% received 3 or more. Some Beers drugs have been associated with delirium and falls. When compared to Baystate patients who did not receive a high severity medication, those who did had an increased risk of mortality (7.8% vs. 5.2%), longer length of stay (5.5 days vs. 3.9 days) and higher costs ($11,240 vs. 6243). Specific Aims: 1. Quantify the impact of synchronous electronic alerts on physician prescribing of high-severity Beers' list drugs to hospitalized patients over the age of 65 years. 2. Compare physician reactions to each drug-specific alert Project Description: We will develop a series of clinical alerts in CIS, Baystate's computerized provider order entry system, to reduce the use of potentially inappropriate medications among hospitalized elders. We will randomize providers to electronic alerts or usual care. Whenever a provider randomized to alerts attempts to place an order for a high-risk medication on the Beers list and the intended recipient is over 65 years of age, a synchronous alert (i.e. a "pop-up") will inform the physician about the risks associated with the medication and will propose safer alternatives. We will collect data on physician ordering and patient outcomes comparing the number of Beers list prescriptions from providers receiving electronic alerts to those not receiving alerts. Our anticipated outcome is a decrease in inappropriate prescribing during the period when the electronic alerts are activated. Other potential outcomes include decrease in len

Interventions

  • BEHAVIORAL Pop-up alert

Trial Details

FieldValue
Enrollment Target 719 participants
Start Date 2013-04
Est. Completion 2013-06
Phase NA

Sponsor

Baystate Medical Center

36 total trials

What the Registry Record Tells You About NCT01034761

The ClinicalTrials.gov registry entry for NCT01034761 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 719 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Baystate Medical Center, which has 36 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Pop-up alert is the first listed.

NCT01034761 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01034761 about?

NCT01034761 is a clinical study titled "Using Clinical Alerts to Decrease Inappropriate Medication Prescribing". Introduction: The Beers list identifies medications that should be avoided in persons 65 years or older because they are ineffective, pose an unnecessarily high risk, or a safer alternative is available. In a recent study, we found a high rate of prescribing of Beers list medications to hospitalize...

What is the current status of trial NCT01034761?

This trial is currently completed. It is a NA study. The enrollment target is 719 participants. The study started on 2013-04. Estimated completion is 2013-06.

What interventions are being tested in trial NCT01034761?

The interventions under investigation include: Pop-up alert (BEHAVIORAL).

Who is sponsoring clinical trial NCT01034761?

This trial is sponsored by Baystate Medical Center, which has 36 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.